Clinical Trials Directory

We are doing this study to collect and store information and samples that will be used for future research studies about transplants.

We are doing this study to collect and store your medical information and specimens for use in future research studies to understand heart function and disease.

We are doing this study to find out how well an emotion regulation skills training program can help expecting mothers lower stress during pregnancy and improve their heart rate.

What happens in this study? - People will do a 30-minute interview by phone or Zoom - The interview will be recorded - No follow-up visits or interviews will happen after that

This study includes several steps and lasts about 208 days in total. It begins with a screening period that lasts 28 days. During this time, you will have a full physical exam, your medical history will be reviewed, and you will have routine lab tests, a heart test called an electrocardiogram, and a sensor placed to check your blood sugar levels. If you qualify and choose to join, you will be randomly assigned on the first dose day to receive either the study drug, called CNP-103, or a placebo, which does not contain any active medicine. The medicine or placebo will be given through a vein. The treatment period lasts 90 days, followed by another 90 days of follow-up. During this time, doctors will check how your body reacts to the medicine and how safe it is.

Everyone who shows interest and passes an early screening will be invited to join all three design group sessions. At the first session, the team will explain what the sessions are about, the benefits and risks, and ask people to give consent. They will also complete some short assessments. The total time for all three sessions will be about three hours, and the team will schedule them at times that work best for the doctors, patients, and caregivers taking part. All three sessions will be held online. In these sessions, doctors and patient or caregiver participants will help design and improve a new tool that supports medical decision making.

This study does not require much extra time from patients, but doctors will check on them closely for two years. People in the study are placed into groups by chance. Two out of every three people will get the new shoulder device, and one out of three will get the regular device that uses a stem.

We are building a database of people who would like to be contacted about future dermatology research studies. This is a way for people who are interested in participating in research opportunities to learn about a research study that they may not have otherwise known about.